Aug 05, 2026
https://www.streetinsider.com/Business+Wire/LifeMine+Raises+%24263+Million+to+Accelerate+the+Clinical+Development+of+LIFE-001%2C+a+Structurally+and+Mechanistically+Novel+Calcineurin+Activation+Inhibitor+Designed+to+Transform+Organ+Transplantation/26877757.html
GSK plc has invested $188M in LifeMine Therapeutics, Inc.